PubMed · 1994 · 23 citations · 0 references
Life SciencesCell BiologyHematologyCell TherapyRegenerative MedicineTransfusion MedicineBlood PreservationHematologic DisordersHematopoietic DevelopmentHematopoietic DifferentiationHematopoietic Stem Cell BiologyHematopoietic Stem CellsCord Blood CellsCord Blood CryopreservationDifferentiation Of Hematopoietic ProgenitorsProgenitor CellsUmbilical Cord Blood Processing
Human cord blood mononuclear cells (MNCs) purified by Ficoll-Hypaque gradient centrifugation were cryopreserved in a vitreous state. The vitrification solution was MEM-alpha medium containing 4-8 mol/l (M) ethylene glycol (EG). A pellet of 1.5-2.0 x 10(6) MNCs was added with 10 microliters of 1 M EG and then 50 microliters of high concentration EG at room temperature (the final concentration was 4-8 M EG). The cell suspension was directly plunged into liquid nitrogen, stored for various periods and rapidly warmed in a water bath at 37 degrees C. The vitrification solution was removed by addition of MEM-alpha medium containing 1 M sucrose. The present experiments demonstrated that a vitrification solution consisting of 8 M EG produced the highest recovery rate for MNCs (89.5 +/- 8.5%), CFU-GM (66.6 +/- 20.8%) and BFU-E (66.5 +/- 22.8%) and the highest Trypan blue viability (98.7 +/- 0.4%). This ultrarapid cryopreservation method may be useful for the preservation of hematopoietic progenitor cells.